global growth. The regulatory environment is evolving fast on two major dimensions—intellectual property (IP) and affordability. The biosimilars [drugs similar to innovator biologic drugs] and generic drugs markets are already well-developed in India. We have competition for our biologic Gonal F
10.45 AM Jan 8th
i can`t believe how people are not able to understand what biocon is !! biocon is a world class biopharma firm, that has world class talent pool of scientists!! its trastuzumab biosimilar is showing much better results than herceptin which generates 40,000 crores alone in revenue for roche!! it
10.07 AM Jan 5th
Hope S. Rugo, professor of medicine at the University of California, San Francisco, said: This study was the last major step of a multiple-phased program to demonstrate that proposed biosimilar trastuzumab meets the criteria for equivalence in comparison to branded trastuzumab.
5.40 PM Dec 28th 2016
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.